Literature DB >> 3193910

Resistance of Pseudomonas pseudomallei to normal human serum bactericidal action.

G Ismail1, N Razak, R Mohamed, N Embi, O Omar.   

Abstract

The effect of human normal serum (HNS) on Pseudomonas pseudomallei was determined. It is apparent from our data that the organism is resistant to the normal serum bactericidal mechanism. Ancillary experiments to confirm this serum-resistant property of P. pseudomallei were done by examining the effects of growth phase conditions of the bacteria (i.e., logarithmic and stationary phases) and different buffered systems used as diluent in our bactericidal assay. Results obtained showed similar degree of resistance to serum bactericidal killing by 5 strains of the organisms tested. The possible survival advantage of serum-resistance property to P. pseudomallei as bacterial pathogens known to invade the blood stream is discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3193910     DOI: 10.1111/j.1348-0421.1988.tb01426.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  13 in total

1.  Fate of a Burkholderia pseudomallei lipopolysaccharide mutant in the mouse macrophage cell line RAW 264.7: possible role for the O-antigenic polysaccharide moiety of lipopolysaccharide in internalization and intracellular survival.

Authors:  S Arjcharoen; C Wikraiphat; M Pudla; K Limposuwan; D E Woods; S Sirisinha; P Utaisincharoen
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

Review 2.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition.

Authors:  Shauna L Reckseidler-Zenteno; Rebekah DeVinney; Donald E Woods
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

4.  In Vitro and In Vivo studies of monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei and Burkholderia mallei.

Authors:  Shimin Zhang; Shaw-Huey Feng; Bingjie Li; Hyung-Yong Kim; Joe Rodriguez; Shien Tsai; Shyh-Ching Lo
Journal:  Clin Vaccine Immunol       Date:  2011-03-30

5.  Identification and characterization of a two-component regulatory system involved in invasion of eukaryotic cells and heavy-metal resistance in Burkholderia pseudomallei.

Authors:  A L Jones; D DeShazer; D E Woods
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

6.  Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes.

Authors:  A M Egan; D L Gordon
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

7.  Siderophore production by Pseudomonas pseudomallei.

Authors:  H M Yang; W Chaowagul; P A Sokol
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

8.  Ability of Pseudomonas pseudomallei malleobactin to acquire transferrin-bound, lactoferrin-bound, and cell-derived iron.

Authors:  H Yang; C D Kooi; P A Sokol
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

9.  Flagella are virulence determinants of Burkholderia pseudomallei.

Authors:  K L Chua; Y Y Chan; Y H Gan
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils.

Authors:  Michael E Woodman; Randall G Worth; R Mark Wooten
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.